About
Matthew H. Kulke, MD is Chief of Hematology/Oncology at Boston Medical Center and Co-Director of the BU/BMC Cancer Center. He is also the Zoltan Kohn Professor at Boston University Chobanian & Avedisian School of Medicine (Boston University Chobanian & Avedisian School of Medicine). Dr. Kulke is internationally recognized for his expertise in neuroendocrine tumors and has led numerous national and ... international clinical trials resulting in new drugs and therapies for neuroendocrine tumors. Dr. Kulke has published more than 200 peer-reviewed publications on preclinical and clinical research in this area. He is a member of the Shipley Prostate Cancer Research Center at Boston University Chobanian & Avedisian School of Medicine and also the Evans Center for Interdisciplinary Biomedical Research at Boston University.
-
Departments
-
Specialties
Neuroendocrine tumors, gastrointestinal cancer, carcinoid tumors
-
Contact
617.638.6428 -
Primary Location
830 Harrison Avenue
Boston, MA 02118
-
Administrative Title
Zoltan Kohn Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University. Member, Shipley Prostate Cancer Research Center at Boston University Chobanian and Avedisian School of Medicine.
-
Residency
Internal Medicine, Brigham and Women’s Hospital
-
Fellowship
Medical Oncology, Dana-Farber Cancer Institute
-
Education
University of California San Francisco School of Medicine, 1992
-
Board Certifications
Medical Oncology, American Board of Internal Medicine